IP Library Granted Patent US 9,206,404
Granted Patent B2
US 9,206,404 · App. 12/592,852 · Granted Dec 8, 2015

Method of deleting an IgM gene in an isolated rat cell

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,206,404
App. No.
12/592,852
Granted
Dec 8, 2015
Kind
B2
Abstract

Disclosed herein are methods and compositions for genome editing of one or more loci in a rat, using fusion proteins comprising a zinc-finger protein and a cleavage domain or cleavage half-domain. Polynucleotides encoding said fusion proteins are also provided, as are cells comprising said polynucleotides and fusion proteins.

Claims (17)

1. A method for making a deletion in an endogenous IgM gene, the method comprising:

introducing mRNA into an isolated rat cell, wherein the mRNA comprises

(i) mRNAs encoding a first zinc finger nuclease (ZFN) that binds to a first target site in an endogenous rat IgM gene wherein the first ZFN comprises a cleavage domain and a zinc finger protein, wherein the first zinc finger protein-comprises the following recognition helices in the following order:

DRSHLTR (SEQ ID NO:41);

RSDALTQ (SEQ ID NO:40);

DRSDLSR (SEQ ID NO:28);

RSDALAR (SEQ ID NO:39);

RSDSLSA (SEQ ID NO:38); and

TSSNRKT (SEQ ID NO:37), and

(ii) mRNA encoding a second ZFN that binds to a second target site in the endogenous rat IgM gene, wherein the second ZFN comprises a cleavage domain and a zinc finger protein comprising the following recognition helices in the following order:

NKVGLIE (SEQ ID NO:46);

TSSDLSR (SEQ ID NO:45);

RSDHLSR (SEQ ID NO:44);

RSDNLSE (SEQ ID NO:43); and

QNAHRKT(SEQ ID NO:42),

such that the first and second ZFNs are expressed, dimerize and cleave the endogenous rat IgM gene and non-homologous end joining (NHEJ) occurs causing the cell to have a deletion in the endogenous rat IgM gene.

2. The method of claim 1 , wherein the cleavage domain is a Type IIS restriction endonuclease cleavage domain.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2015
From: CUI, XIAOXIA; GEURTS, ARON M
To: SIGMA-ALDRICH CO LLC
Reel/Frame 034918/0379 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2010
From: URNOV, FYODOR
To: SANGAMO BIOSCIENCES, INC.
Reel/Frame 024127/0671 →